Document:

<PAGE>

                                                                    Exhibit 10.5

                            PARADIGM GENETICS INC.

                        FOUNDER PROPRIETARY INFORMATION
                           AND INVENTIONS AGREEMENT

     In consideration of my employment or continued employment by Paradigm
Genetics Inc., a North Carolina corporation (the "Company"), and the
compensation now and hereafter paid to me, I hereby agree as follows:

     1. Proprietary Information and Confidentiality

        1.1 Recognition of Company's Rights; Nondisclosure. I acknowledge and
agree that during and by reason of my employment with the Company, I may have
had access to or received, or may have access to or receive, Proprietary
Information (defined below). At all times during my employment and thereafter, I
will hold in strictest confidence, and in a fiduciary capacity for the benefit
of the Company, and will not disclose, use, lecture upon or publish any
Proprietary Information, except as such disclosure, use or publication may be
required in connection with my work for the Company, or unless an executive
officer of the Company expressly authorizes in writing such disclosure, use or
publication. I agree that all Proprietary Information shall be the sole and
exclusive property of the Company and its successors and assigns. I agree that
my obligations under this Agreement shall continue as to each item of
Proprietary Information until such item has become public knowledge through no
fault of mine and by proper means without breach of this Agreement.

        1.2 Proprietary Information. The term "Proprietary Information" shall
mean any and all confidential, private, secret or proprietary knowledge, data or
information of or concerning the Company and/or its affiliates, including, but
not limited to, information relating to products, processes, know-how, trade
secrets, designs, formulae, patterns, methods, techniques, developmental or
experimental work, improvements, discoveries, inventions, devices, ideas, source
and object codes, data, programs, other works of authorship, specifications,
plans for research and development, marketing and selling, business plans,
projections, budgets and unpublished financial statements, licenses, prices and
costs, suppliers and customers, training techniques and materials, and the
skills and compensation of other employees of the Company.

        1.3 Third Party Information. I understand, in addition, that the Company
has received and in the future will receive from third parties confidential or
proprietary information ("Third Party Information") subject to a duty on the
Company's part to maintain the confidentiality of such information and to use it
only for certain limited purposes. During the term of my employment and
thereafter, I will hold Third Party Information in the strictest confidence and
will not disclose to anyone (other than the Company's employees and agents who
need to know such information in connection with their work for the Company) or
use, except as required in my work for the Company, Third Party Information
unless expressly authorized in writing by an executive officer of the Company.
<PAGE>

     2. Assignment of Inventions and Other Developments.

        2.1 Disclosure of Inventions and Other Developments. I agree to hold in
a fiduciary capacity for the benefit of the Company and to make full and prompt
disclosure to the Company of all inventions, discoveries, developments, devices,
processes, designs, methods, software, works of authorship, and improvements,
whether or not patentable or copyrightable, which are made, conceived, created,
discovered, developed, or reduced to practice by me, alone or jointly with
others, or otherwise, during the term of my employment by the Company and during
the period of six (6) months after the termination of such employment, that
relate in any way to the Company's business or actual or anticipated research or
development, or result in any way from any work performed by me for or on behalf
of the Company (all of which inventions and other such items described above are
collectively referred to as "Developments"). I acknowledge that all original
works of authorship which are made by me (solely or jointly with others) within
the scope of my employment and which are protectable by copyright are "works
made for hire," pursuant to the United States Copyright Act.

        2.2 Assignment of Inventions and Other Developments; Records. I hereby
assign and agree to assign to the Company (or any entity or person designated by
the Company) all of my right, title and interest in and to all Developments and
all intellectual property or other proprietary information or rights with
respect thereto (the "Proprietary Rights"), including without limitation all
related patents, patent applications, copyrights and copyright applications, and
trade secrets. I agree to keep and maintain complete, accurate and current
accounts and records (including notes, sketches, and drawings and in any other
form that may be required by the Company from time to time) of all Developments
and Proprietary Information made, conceived, created, discovered or developed by
me, which records shall be available to and shall be and remain the sole and
exclusive property of the Company at all times.

        2.3 Enforcement of Proprietary Rights. I will assist the Company in
every proper way to obtain, and from time to time enforce, United States and
foreign Proprietary Rights relating to all Developments in any and all
countries. To that end I will execute, verify and deliver such documents and
perform such other acts (including appearances as a witness) as the Company may
reasonably request for use in applying for, obtaining, perfecting, evidencing,
sustaining and enforcing such Proprietary Rights and the assignment thereof. In
addition, I will execute, verify and deliver assignments of such Proprietary
Rights to the Company or its designee. My obligation to assist the Company with
respect to Proprietary Rights relating to all Developments in any and all
countries shall continue beyond the termination of my employment, but the
Company shall compensate me at a reasonable rate after my termination for the
time actually spent by me at the Company's request on such assistance.

        2.4 Prior Inventions. Except as I have notified the Company in writing
prior to the date of this Agreement, there are no inventions, discoveries or the
like which I have made prior to the commencement of my employment with the
Company and which are excluded from the scope of this Agreement. The Company
acknowledges and agrees that I have notified the Company of my agreements with
my former employer, Novartis Crop Protection, Inc., and its affiliates
("Novartis") under which Novartis has certain rights with respect to inventions,
discoveries or the like made by me in connection with my employment

                                       2
<PAGE>

with Novartis. I have not and will not use any trade secrets of Novartis in the
course of my employment with the Company that may expose the Company or any
employees of the Company to any liability under any agreement, rule, regulation
or statute. No patent, discovery, invention, improvement, process or device
made, discovered or developed by me while employed with Novartis or within six
months subsequent to such employment has or will be used in any business of the
Company in any manner that violates or infringes the intellectual property
rights of Novartis or violates any agreement between me and Novartis.

     3. Additional Activities. I agree that during the period of my employment
by the Company I will not, without the Company's express written consent, engage
in any employment or business activity that is competitive with, or would
otherwise conflict with, my employment by the Company. I agree further that for
the period of my employment by the Company, and for twelve (12) months after the
date of termination of my employment by the Company, I will not induce any
employee of the Company to leave the employ of the Company.

     4. Return of Company Property. When I leave the employ of the Company, I
will deliver promptly to the Company any and all records, drawings, sketches,
notes, memoranda, reports, specifications, devices, formulae, and documents,
together with all copies thereof, any other material containing or disclosing
any Developments, Third Party Information or Proprietary Information of the
Company, and other property that I shall have received in connection with or
otherwise possess by virtue of my employment with the Company.

     5. Remedies. I agree that any breach of this Agreement by me is likely to
cause the Company substantial and irrevocable damage and, therefore, I agree
that the Company shall have the right to enforce this Agreement by injunction,
specific performance or other equitable relief, without bond and without
prejudice to any other rights and remedies that the Company may have for breach
of this Agreement.

     6. General Provisions.

        6.1 Governing Law; Consent to Jurisdiction. This Agreement will be
governed by and construed according to the laws of the State of North Carolina,
without regard to conflicts of laws principles. I hereby expressly consent to
the personal jurisdiction of the state and federal courts located in North
Carolina for any lawsuit filed there against me by the Company arising from or
related to this Agreement.

        6.2 Severability. In case any one or more of the provisions contained in
this Agreement shall, for any reason, be held to be invalid, illegal or
unenforceable in any respect, such invalidity, illegality or unenforceability
shall not affect the other provisions of this Agreement, and this Agreement
shall be construed as if such invalid, illegal or unenforceable provision had
never been contained herein. If moreover, any one or more of the provisions
contained in this Agreement shall for any reason be held to be excessively broad
as to duration, scope, activity or subject, it shall be construed by limiting
and reducing it, so as to be enforceable to the extent compatible with the
applicable law as it shall then appear.

        6.3 Employment. I understand that this Agreement does not constitute a
contract of employment and does not imply that my employment will continue for
any period of time.

                                       3
<PAGE>

        6.4 Other Provisions. This Agreement will be binding upon my heirs,
executors, administrators and other legal representatives and will be for the
benefit of the Company, its successors, and its assigns. The provisions of this
Agreement shall survive the termination of my employment and the assignment of
this Agreement by the Company to any successor in interest or other assignee. No
waiver by the Company of any breach of this Agreement shall be a waiver of any
preceding or succeeding breach. No waiver by the Company of any right under this
Agreement shall be construed as a waiver of any other right. The obligations
pursuant to this Agreement shall apply to any time during which I was previously
employed, or am in the future employed, by the Company as a consultant if no
other agreement governs nondisclosure and assignment of inventions during such
period. This Agreement is the final, complete and exclusive agreement of the
parties with respect to the subject matter hereof and supersedes and merges all
prior discussions between us. No modification of or amendment to this Agreement,
nor any waiver of any rights under this Agreement, will be effective unless in
writing and signed by the party to be charged.

                        [Signatures appear on next page]

                                       4
<PAGE>

     This Agreement shall be effective as of the first day of my employment with
the Company, namely: September 9, 1997.
                     -----------------

                              PARADIGM GENETICS INC.

                              By:  /s/ Scott J. Uknes
                                  ----------------------------------
                                        Name: Scott J. Uknes
                                        Title: Vice-President
                                        Address: 85 Alexander

                                /s/ John Ryals
                              -------------------------------------
                                        John Ryals
                              --------------------------------------
                                        (Printed Name)

                                   Dated:  February 12, 1998<PAGE>

                                                                    EXHIBIT 10.6

              AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

     AGREEMENT, dated as of February 12, 1998 and amended and restated as of
March 12, 1999 and January 21, 2000 (this "Agreement"), by and among PARADIGM
GENETICS INC., a North Carolina corporation (the "Company"), and the persons
identified as "Investors" and "Founders" on Exhibit A attached hereto.
                                            ---------

                                  BACKGROUND

     WHEREAS, certain of the Investors (the "Series A Investors") and the
Company previously entered into the Registration Rights Agreement dated as of
February 12, 1998 and amended as of March 6, 1998 and May 29, 1998 (the
"Original Registration Rights Agreement");

     WHEREAS, the Original Registration Rights Agreement was entered into in
connection with the Series A Preferred Stock Purchase Agreement dated as of
February 12, 1998 among the Company and the Series A Investors, as amended;

     WHEREAS, certain of the Investors and the Company amended and restated the
Original Registration Rights Agreement in its entirety by entering into an
Amended and Restated Registration Rights Agreement dated as of March 12, 1999
(the "Restated Registration Rights Agreement");

     WHEREAS, the Restated Registration Rights Agreement was entered into in
connection with the Series B Preferred Stock Purchase Agreement dated as of
March 12, 1999 among the Company and certain of the Investors;

     WHEREAS, the Company and certain of the Investors on the date hereof are
entering into a Series C Preferred Stock Purchase Agreement (the "Series C
Purchase Agreement");

     WHEREAS, in connection with the Series C Purchase Agreement, the Investors
wish to amend and restate the Restated Registration Rights Agreement in its
entirety by entering into this Amended and Restated Registration Rights
Agreement (this "Agreement"), and certain of the parties' obligations under the
Series C Purchase Agreement are conditioned upon the execution and delivery of
this Agreement; and

     WHEREAS, the Founders are holders of shares of Common Stock of the Company;

     NOW, THEREFORE, in consideration of the mutual promises and covenants set
forth in this Agreement, and intending to be legally bound, the parties agree as
follows:
<PAGE>

SECTION 1.  RESTRICTIONS ON TRANSFERABILITY OF SECURITIES; REGISTRATION RIGHTS.

       1.1  Certain Definitions.  As used in this Agreement, the following terms
shall have the meanings set forth below:

            (a) "Commission" shall mean the Securities and Exchange Commission
or any other federal agency at the time administering the Securities Act.

            (b) "Exchange Act" shall mean the Securities Exchange Act of 1934,
as amended, or any similar successor federal statute and the rules and
regulations thereunder, all as the same shall be in effect from time to time.

            (c) "Founders" shall mean those persons named as such on Exhibit A
                                                                     ---------
hereto.

            (d) "Holder" shall mean any Investor who holds Registrable
Securities and any holder of Registrable Securities to whom the registration
rights conferred by this Agreement have been transferred in compliance with
Section 1.2 and Section 1.12 hereof.

            (e) "Initiating Holders" shall mean any Holder or Holders of
Registrable Securities who in the aggregate hold(s) not less than twenty percent
(20%) of the Registrable Securities.

            (f) "Investors" shall mean those persons named as such on Exhibit A
                                                                      ---------
hereto.

            (g) "Other Stockholders" shall mean persons other than Holders who,
by virtue of agreements with the Company, are entitled to include their
securities in certain registrations hereunder.

            (h) "Registrable Securities" shall mean (i) shares of Common Stock
issued or issuable pursuant to the conversion of the Series A Preferred, Series
B Preferred and Series C Preferred Stock and (ii) any Common Stock issued as a
dividend or other distribution with respect to or in exchange for or in
replacement of the shares referenced in (i) above; provided, however, that
Registrable Securities shall not include any shares of Common Stock (A) which
have previously been registered, (B) which have been sold to the public either
pursuant to a registration statement or an exemption from registration under the
Securities Act (including Rule 144), (C) which have been sold in a private
transaction in which the transferor's rights under this Agreement are not
assigned or (D) with respect to which shares this Agreement has terminated
pursuant to Section 1.17.

            (i) The terms "register," "registered" and "registration" shall
refer to a registration effected by preparing and filing a registration
statement in compliance with the Securities Act and applicable rules and
regulations thereunder, and the declaration or ordering of the effectiveness of
such registration statement.

            (j) "Registration Expenses" shall mean all expenses incurred in
effecting any registration pursuant to this Agreement, including, without
limitation, all registration, qualification, and filing fees, printing expenses,
escrow fees, fees and disbursements of counsel

                                       2
<PAGE>

for the Company, blue sky fees and expenses, and expenses of any regular or
special audits incident to or required by any such registration, but shall not
include Selling Expenses, fees and disbursements of counsel for the Holders, and
the compensation of regular employees of the Company, which shall be paid in any
event by the Company.

       (k) "Rule 144" shall mean Rule 144 as promulgated by the Commission under
the Securities Act, as such Rule may be amended from time to time, or any
similar successor rule that may be promulgated by the Commission.

       (l) "Rule 145" shall mean Rule 145 as promulgated by the Commission under
the Securities Act, as such Rule may be amended from time to time, or any
similar successor rule that may be promulgated by the Commission.

       (m) "Securities Act" shall mean the Securities Act of 1933, as amended,
or any similar successor federal statute and the rules and regulations
thereunder, all as the same shall be in effect from time to time.

       (n) "Selling Expenses" shall mean all underwriting discounts, selling
commissions and stock transfer taxes applicable to the sale of Registrable
Securities and fees and disbursements of counsel for any Holder or Founder.

       (o) "Series A Preferred" shall mean the Company's Series A Preferred
Stock, par value $0.01 per share.

       (p) "Series B Preferred" shall mean the Company's Series B Preferred
Stock, par value $0.01 per share.

       (q) "Series C Preferred" shall mean the Company's Series C Preferred
Stock, par value $0.01 per share.

  1.2  Restrictions on Transfer.

       (a) Each Holder agrees not to make any disposition of all or any portion
of the Registrable Securities unless and until either:

           (i)   there is then in effect a registration statement under the
Securities Act covering such proposed disposition and such disposition is made
in accordance with such registration statement; or

           (ii)  (A)  such Holder shall have notified the Company of the
proposed disposition and shall have furnished the Company with a detailed
statement of the circumstances surrounding the proposed disposition and the
transferee has agreed in writing for the benefit of the Company to be bound by
this Section 1.2, and (B) if requested by the Company, such Holder shall have
furnished the Company with an opinion of counsel, reasonably satisfactory to the
Company, that such disposition will not require registration of such shares
under the Securities Act.

           (iii) Notwithstanding the provisions of Sections 1.2(a)(i) and (ii)
above, no such registration statement or opinion of counsel shall be necessary
for a transfer by a

                                       3
<PAGE>

Holder which is (A) a partnership, to its partners or retired partners in
accordance with their interests in the partnership, (B) a corporation, to its
shareholders in accordance with their interest in the corporation, (C) a limited
liability company, to its members or former members in accordance with their
interest in the limited liability company, or (D) to the Holder's immediate
family member or trust for the benefit of an individual Holder, provided that a
condition precedent to any such transfer is that the transferee agrees to be
subject to the terms of this Section 1.2 to the same extent as if such
transferee were an original Holder hereunder.

          (b) Each certificate representing Registrable Securities shall (unless
otherwise permitted by the provisions of this Agreement) be stamped or otherwise
imprinted with a legend substantially similar to the following (in addition to
any legend required under applicable state securities laws):

          THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
          UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD OR
          TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL
          REGISTERED UNDER SUCH ACT OR UNLESS THE COMPANY HAS RECEIVED AN
          OPINION OF COUNSEL OR OTHER EVIDENCE, SATISFACTORY TO THE COMPANY AND
          ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.

          (c) The Company shall be obligated to reissue promptly unlegended
certificates at the request of any Holder thereof if the Holder shall have
obtained an opinion of counsel at such Holder's expense (which counsel may be
counsel to the Company) reasonably acceptable to the Company to the effect that
the securities proposed to be disposed of may lawfully be so disposed of without
registration, qualification or legend.

     1.3  Demand Registration.

          (a) If the Company shall receive from the Initiating Holders, at any
time not before the earlier of (x) 180 days after the effective date of the
first registration statement filed by the Company covering an underwritten
offering of any of its securities to the general public or (y) February 1, 2003,
a written request that the Company effect any registration with respect to all
or a part of the Registrable Securities at an aggregate offering price of not
less than $5,000,000, then the Company will:

              (i) promptly give written notice of the proposed registration to
all other Holders and the Founders; and

             (ii) use its best efforts to effect such registration (including,
without limitation, filing post-effective amendments, appropriate qualifications
under applicable blue sky or other state securities laws, and appropriate
compliance with the Securities Act) as would permit or facilitate the sale and
distribution of all or such portion of such Registrable Securities as are
specified in such request, together with all or such portion of the Registrable
Securities of any Holder or Holders joining in such request as are specified in
a written request received by the Company within 15 days after such written
notice from the Company is mailed or delivered.

                                       4
<PAGE>

     The Company shall not be obligated to effect, or to take any action to
effect, any such registration pursuant to this Section 1.3:

            (A) in any particular jurisdiction in which the Company would be
     required to execute a general consent to service of process in effecting
     such registration, qualification, or compliance, unless the Company is
     already subject to service in such jurisdiction and except as may be
     required by the Securities Act;

            (B) after the Company has initiated one such registration pursuant
     to Section 1.3(a) after the Company's initial public offering (counting for
     these purposes only registrations which have been declared or ordered
     effective);

            (C) for such periods of time during the period starting with the
     date 60 days prior to the Company's good faith estimate of the date of
     filing, and ending on a date 180 days after the effective date, of a
     Company-initiated registration, as required by the underwriters managing
     the offering related to such registration; provided that the Company is
     actively employing in good faith all reasonable efforts to cause such
     registration statement to become effective;

            (D) if the Initiating Holders propose to dispose of shares of
     Registrable Securities which may be immediately registered on Form S-3
     pursuant to a request made under Section 1.5 hereof;

            (E) if, in the event that such offering is the Company's initial
     public offering, the Initiating Holders do not request that such offering
     be underwritten on a firm commitment basis by underwriters selected by the
     Initiating Holders (subject to the reasonable consent of the Company);

            (F) if the Company and the Initiating Holders are unable to obtain
     the commitment of the underwriter described in clause (E) above to
     underwrite the offering on a firm commitment basis;

            (G) if, in the event that such offering is after the Company's
     initial public offering, the Initiating Holders request that such offering
     be an underwritten offering; or

            (H) unless and until the valuation of the Corporation is at least
     $50,000,000 prior to giving effect to the offering, as determined by the
     managing underwriter for the offering in the event that such offering is
     the Company's initial public offering, and as determined by reference to
     the trading price of the Company's stock in the event that such offering is
     subsequent to the Company's initial public offering.

     In the event that a withdrawal of a registration by the Holders is based
upon material adverse information relating to the Company that is different from
the information made available (upon request from the Company or otherwise) to
the Holders requesting registration at the time of their request for
registration under this Section 1.3, or if the Company delays such registration
pursuant to the terms hereof and the holders of a majority of the Registrable
Securities held by the Initiating Holders with respect to such registration
elect not to proceed

                                       5
<PAGE>

with such registration, such registration shall not be treated as a counted
registration for purposes of this Section 1.3 hereof.

     (b) Subject to the foregoing clauses (A) through (H), the Company shall
file a registration statement covering the Registrable Securities so requested
to be registered as soon as practicable after receipt of the request or requests
of the Initiating Holders; provided, however, that if (i) in the good faith
judgment of the Board of Directors of the Company, such registration would be
materially detrimental to the Company, and the Board of Directors of the Company
concludes, as a result, that it is essential to defer the filing of such
registration statement at such time, and (ii) the Company shall furnish to such
Holders a certificate signed by the President of the Company stating that in the
good faith judgment of the Board of Directors of the Company, it would be
materially detrimental to the Company for such registration statement to be
filed in the near future and that it is, therefore, essential to defer the
filing of such registration statement, then the Company shall have the right to
defer such filing, upon furnishing such certificate, for a period of not more
than 120 days after receipt of the request of the Initiating Holders, and,
provided further, that the Company shall not defer its obligation in this manner
more than once in any rolling 12-month period.

     The registration statement filed pursuant to the request of the Initiating
Holders may, subject to the provisions of Sections 1.3(b) and 1.14 hereof,
include other securities of the Company, with respect to which registration
rights have been granted (including with respect to the Founders), and may
include securities of the Company being sold for the account of the Company.

     (c) The right of any Holder to registration pursuant to Section 1.3(a)
shall be conditioned upon such Holder's participation in such underwriting and
the inclusion of such Holder's Registrable Securities in the underwriting to the
extent provided herein.  A Holder may elect to include in such underwriting all
or a part of the Registrable Securities he holds.

     (d) If the Company shall request inclusion in any registration pursuant to
Section 1.3 of securities being sold for its own account, or if other persons
shall request inclusion in any registration pursuant to Section 1.3, then the
Company shall provide the Initiating Holders with written notice of such
participation and the Initiating Holders shall, on behalf of all Holders, offer
to include such securities in the underwriting and may condition such offer on
their acceptance of the further applicable provisions of this Section 1
(including Section 1.13).  The Company shall (together with all Holders and
other persons proposing to distribute their securities through such
underwriting) enter into an underwriting agreement in customary form with the
representative of the underwriter or underwriters selected for such underwriting
by the Initiating Holders, to which the Company has reasonably consented.
Notwithstanding any other provision of this Section 1.3, if the representative
of the underwriters advises the Initiating Holders in writing that marketing
factors require a limitation on the number of shares to be underwritten, the
number of shares to be included in the underwriting or registration shall be
allocated as set forth in Section 1.14 hereof.  If a person who has requested
inclusion in such registration as provided above does not agree to the terms of
any such underwriting, such person shall be excluded therefrom by written notice
from the Company, the underwriter or the Initiating Holders.  The securities so
excluded shall also be withdrawn from registration.  Any Registrable Securities
or other securities excluded or withdrawn from such underwriting shall also be
withdrawn from such registration.  If shares are so withdrawn from the
registration and if the number of shares to be included in such registration was
previously reduced as a result of

                                       6
<PAGE>

marketing factors pursuant to this Section 1.3(d), then the Company shall offer
to all Holders who have retained rights to include securities in the
registration the right to include additional securities in the registration in
an aggregate amount equal to the number of shares so withdrawn, with such shares
to be allocated among such Holders requesting additional inclusion in accordance
with Section 1.14.

     1.4  Piggy-Back Registration.

          (a)  If the Company shall determine to register any of its securities
either for its own account or the account of a security holder or holders
exercising their respective demand registration rights (other than pursuant to
Section 1.5 hereof), other than a registration relating solely to employee
benefit plans, or a registration relating to a corporate reorganization or other
transaction under Rule 145, or a registration on any registration form that does
not permit secondary sales, the Company will:

          (i)  promptly give to each Holder and Founder written notice thereof;
and

          (ii) use its best efforts to include in such registration (and any
related qualification under blue sky laws or other compliance), except as set
forth in Section 1.4(b) below, and in any underwriting involved therein, all the
Registrable Securities and shares of Common Stock held by the Founders (the
"Founders' Shares") specified in a written request or requests, made by any
Holder or Founder and received by the Company within 15 days after the written
notice from the Company described in clause (i) above is mailed or delivered by
the Company. Such written request may specify all or a part of a Holder's
Registrable Securities or of a Founder's Shares, as the case may be.

     (b) If the registration of which the Company gives notice is for a
registered public offering involving an underwriting, the Company shall so
advise the Holders and Founders as a part of the written notice given pursuant
to Section 1.4(a)(i). In such event, the right of any Holder or Founder to
registration pursuant to this Section 1.4 shall be conditioned upon such
Holder's or Founder's participation in such underwriting and the inclusion of
such Holder's Registrable Securities or Founder's Shares in the underwriting to
the extent provided herein.  All Holders or Founders proposing to distribute
their securities through such underwriting shall (together with the Company and
the other holders of securities of the Company with registration rights to
participate therein distributing their securities through such underwriting)
enter into an underwriting agreement in customary form with the representative
of the underwriter or underwriters selected by the Company.  Notwithstanding any
other provision of this Section 1.4, if the representative of the underwriters
advises the Company in writing that marketing factors require a limitation on
the number of shares to be underwritten, the representative may (subject to the
limitations set forth below) exclude all Registrable Securities and Founders'
Shares from, or limit the number of Registrable Securities and Founders' Shares
to be included in, the registration and underwriting.  The Company shall so
advise all holders of securities requesting registration, and the number of
shares of securities that are entitled to be included in the registration and
underwriting shall be allocated first to the Company for securities being sold
for its own account and thereafter as set forth in Section 1.14. If any person
does not agree to the terms of any such underwriting, he shall be excluded
therefrom by written notice from the Company or the underwriter.  Any
Registrable Securities, Founders' Shares or other securities excluded or
withdrawn from such underwriting shall be withdrawn

                                       7
<PAGE>

from such registration. If shares are so withdrawn from the registration or if
the number of Registrable Securities or Founders' Shares to be included in such
registration was previously reduced as a result of marketing factors, the
Company shall then offer to all persons who have retained the right to include
securities in the registration the right to include additional securities in the
registration in an aggregate amount equal to the number of shares so withdrawn,
with such shares to be allocated among the persons requesting additional
inclusion in accordance with Section 1.14 hereof.

     1.5  Registration on Form S-3.

          (a) After its initial public offering, the Company shall use its best
efforts to qualify for registration on Form S-3 under the Securities Act or any
comparable or successor form or forms.  After the Company has qualified for the
use of Form S-3, in addition to the rights contained in the foregoing provisions
of this Section 1, Holders of Registrable Securities shall have the right to
request registrations on Form S-3 (such requests shall be in writing and shall
state the number of shares of Registrable Securities to be disposed of and the
intended methods of disposition of such shares by such Holder or Holders),
provided, however, that the Company shall not be obligated to effect any such
registration:  (i) if the Holders, together with the holders of any other
securities of the Company entitled to inclusion in such registration, propose to
sell Registrable Securities and such other securities (if any) on Form S-3 at an
aggregate price to the public of less than $750,000 (ii) in the event that the
Company shall furnish the certification described in paragraph 1.3(b) (but
subject to the limitations set forth therein); (iii) if in any rolling 12-month
period, the Company has effected one such registration in such period; or (iv)
within 180 days of the effective date of any other Company registration (other
than on Form S-8 or Form S-3 with respect to employees' stock).

          (b) If a request complying with the requirements of Section 1.5(a)
hereof is delivered to the Company, the provisions of Sections 1.3(a)(i) and
(ii) (other than subsections (B), (D), (E), (F), (G) and (H)) and Section 1.3(b)
hereof shall apply to such registration. If the registration is for an
underwritten offering, the provisions of Sections 1.3(c) and 1.3(d) hereof shall
in addition apply to such registration.

     1.6  Expenses of Registration.  All Registration Expenses, and in the case
of a demand registration the reasonable fees and expenses of one counsel
representing, and designated by, all the selling Holders (not to exceed
$20,000),  incurred in connection with any registration, qualification or
compliance pursuant to Sections 1.3, 1.4 and 1.5 hereof shall be borne by the
Company.  All Selling Expenses relating to securities so registered shall be
borne by the holders of such securities pro rata on the basis of the number of
shares of securities so registered on their behalf, as shall any other expenses
in connection with the registration required to be borne by the holders of such
securities.

     1.7  Registration Procedures.  In the case of each registration effected by
the Company pursuant to Section 1, the Company will keep each Holder (including,
for these purposes, each Founder participating in a registration) advised in
writing as to the initiation of each registration and as to the completion
thereof. At its expense, the Company will use its best efforts to:

          (a) keep such registration effective for a period of 180 days or until
the Holder or Holders have completed the distribution described in the
registration statement

                                       8
<PAGE>

relating thereto, whichever first occurs; provided, however, that such 180-day
period shall be extended for a period of time equal to the period the Holder
refrains from selling any securities included in such registration at the
request of an underwriter of Common Stock (or other securities) of the Company
or pursuant to Section 1.16;

          (b) prepare and file with the Commission such amendments and
supplements to such registration statement and the prospectus used in connection
with such registration statement as may be necessary to comply with the
provisions of the Securities Act with respect to the disposition of all
securities covered by such registration statement;

          (c) furnish such number of prospectuses and other documents incident
thereto, including any amendment of or supplement to the prospectus, as a Holder
or Founder from time to time may reasonably request;

          (d) notify each seller of Registrable Securities or Founder Shares
covered by such registration statement at any time when a prospectus relating
thereto is required to be delivered under the Securities Act of the occurrence
of any event as a result of which the prospectus included in such registration
statement, as then in effect, includes an untrue statement of a material fact or
omits to state a material fact required to be stated therein or necessary to
make the statements therein not misleading or incomplete in the light of the
circumstances then existing, and at the request of any such seller, prepare and
furnish to such seller a reasonable number of copies of a supplement to or an
amendment of such prospectus as may be necessary so that, as thereafter
delivered to the purchasers of such shares, such prospectus shall not include an
untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary to make the statements therein not misleading or
incomplete in the light of the circumstances then existing;

          (e) use its best efforts to cause all such Registrable Securities
registered pursuant hereunder to be listed on each securities exchange or market
on which similar securities issued by the Company are then listed;

          (f) provide a transfer agent and registrar for all Registrable
Securities registered pursuant to such registration statement and a CUSIP number
for all such Registrable Securities, in each case not later than the effective
date of such registration;

          (g) otherwise use its best efforts to comply with all applicable rules
and regulations of the Commission, and make available to its security holders,
as soon as reasonably practicable, an earnings statement covering the period of
at least 12 months, but not more than 18 months, beginning with the first month
after the effective date of the Registration Statement, which earnings statement
shall conform materially with the provisions of Section 11(a) of the Securities
Act; and

          (h) in connection with any underwritten offering pursuant to a
registration statement filed pursuant to Section 1.3 hereof, the Company will
enter into an underwriting agreement in form reasonably necessary to effect the
offer and sale of Common Stock, provided such underwriting agreement contains
customary underwriting provisions and provided further that if the underwriter
so requests the underwriting agreement will contain customary contribution
provisions.

                                       9
<PAGE>

     1.8  Indemnification.

          (a) The Company will indemnify each Holder, each of such Holder's
officers, directors and partners, legal counsel, and accountants and each person
controlling such Holder within the meaning of Section 15 of the Securities Act,
and each Founder, with respect to which registration, qualification, or
compliance has been effected pursuant to this Section 1, and each underwriter,
if any, and each person who controls within the meaning of Section 15 of the
Securities Act any underwriter, against all expenses, claims, losses, damages,
and liabilities (or actions, proceedings, or settlements in respect thereof)
arising out of or based on any breach of this Agreement by the Company, any
untrue statement (or alleged untrue statement) of a material fact contained in
any prospectus, offering circular, or other document (including any related
registration statement, notification, or the like) incident to any such
registration, qualification, or compliance, or based on any omission (or alleged
omission) to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, or any violation by the
Company of the Securities Act or any rule or regulation thereunder applicable to
the Company and relating to action or inaction required of the Company in
connection with any such registration, qualification, or compliance, and will
reimburse each such Holder, each of its officers, directors, partners, legal
counsel, and accountants and each person controlling such Holder, each such
underwriter, and each person who controls any such underwriter, for any legal
and any other expenses reasonably incurred in connection with investigating and
defending or settling any such claim, loss, damage, liability, or action,
provided that the Company will not be liable in any such case to the extent that
any such claim, loss, damage, liability, or expense arises out of or is based on
any untrue statement or omission based upon written information furnished to the
Company by such Holder or underwriter and stated to be specifically for use
therein, unless such Holder timely provided to the Company additional
information to correct the previously inaccurate or incomplete information. It
is agreed that the indemnity agreement contained in this Section 1.8(a) shall
not apply to amounts paid in settlement of any such loss, claim, damage,
liability, or action if such settlement is effected without the consent of the
Company (which consent has not been unreasonably withheld).

          (b) Each Holder and each Founder will, individually and not jointly,
if Registrable Securities or Founders' Shares held by such Holder or Founder are
included in the securities as to which such registration, qualification, or
compliance is being effected, indemnify the Company, each of its directors,
officers, partners, legal counsel, and accountants and each underwriter, if any,
of the Company's securities covered by such a registration statement, each
person who controls the Company or such underwriter within the meaning of
Section 15 of the Securities Act, each other such Holder and Other Stockholder,
and each of their officers, directors, and partners, and each person controlling
such Holder or Other Stockholder, against all claims, losses, damages and
liabilities (or actions in respect thereof) arising out of or based on any
untrue statement (or alleged untrue statement) of a material fact contained in
any such registration statement, prospectus, offering circular, or other
document, or any omission (or alleged omission) to state therein a material fact
required to be stated therein or necessary to make the statements therein not
misleading, and will reimburse the Company and such Holders, Other Stockholders,
directors, officers, partners, legal counsel, and accountants, persons,
underwriters, or control persons for any legal or any other expenses reasonably
incurred in connection with investigating or defending any such claim, loss,
damage, liability, or action, in each case to the extent, but only to the
extent, that such untrue statement (or alleged untrue statement) or omission (or
alleged omission) is made in such registration statement,

                                       10
<PAGE>

prospectus, offering circular, or other document in reliance upon and in
conformity with written information furnished to the Company by such Holder and
stated to be specifically for use therein provided, however, that the
obligations of such Holder hereunder shall not apply to amounts paid in
settlement of any such claims, losses, damages, or liabilities (or actions in
respect thereof) if such settlement is effected without the consent of such
Holder (which consent shall not be unreasonably withheld); and provided that in
no event shall any indemnity under this Section 1.8 exceed the gross proceeds
from the offering received by such Holder.

          (c) Each party entitled to indemnification under this Section 1.8 (the
"Indemnified Party") shall give notice to the party required to provide
indemnification (the "Indemnifying Party") promptly after such Indemnified Party
has actual knowledge of any claim as to which indemnity may be sought, and shall
permit the Indemnifying Party to assume the defense of such claim or any
litigation resulting therefrom, provided that counsel for the Indemnifying
Party, who shall conduct the defense of such claim or any litigation resulting
therefrom, shall be approved by the Indemnified Party (whose approval shall not
unreasonably be withheld), and the Indemnified Party may participate in such
defense at such party's expense, and provided further that the failure of any
Indemnified Party to give notice as provided herein shall not relieve the
Indemnifying Party of its obligations under this Section 1, to the extent such
failure is not prejudicial. No Indemnifying Party, in the defense of any such
claim or litigation, shall, except with the consent of each Indemnified Party,
consent to entry of any judgment or enter into any settlement that does not
include as an unconditional term thereof the giving by the claimant or plaintiff
to such Indemnified Party of a release from all liability in respect to such
claim or litigation. Each Indemnified Party shall furnish such information
regarding itself or the claim in question as an Indemnifying Party may
reasonably request in writing and as shall be reasonably required in connection
with the defense of such claim and litigation resulting therefrom.

          (d) If the indemnification provided for in this Section 1.8 is held by
a court of competent jurisdiction to be unavailable to an Indemnified Party with
respect to any loss, liability, claim, damage, or expense referred to therein,
then the Indemnifying Party, in lieu of indemnifying such Indemnified Party
hereunder, shall contribute to the amount paid or payable by such Indemnified
Party as a result of such loss, liability, claim, damage, or expense in such
proportion as is appropriate to reflect the relative fault of the Indemnifying
Party on the one hand and of the Indemnified Party on the other in connection
with the statements or omissions that resulted in such loss, liability, claim,
damage, or expense as well as any other relevant equitable considerations. The
relative fault of the Indemnifying Party and of the Indemnified Party shall be
determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission to state a material fact
relates to information supplied by the Indemnifying Party or by the Indemnified
Party and the parties' relative intent, knowledge, access to information, and
opportunity to correct or prevent such statement or omission.

          (e) Notwithstanding the foregoing, to the extent that the provisions
on indemnification and contribution contained in the underwriting agreement
entered into in connection with the underwritten public offering are in conflict
with the foregoing provisions, the provisions in the underwriting agreement
shall control.

     1.9  Information by Holder.  Each Holder of Registrable Securities, and
each Founder participating in a registration, shall furnish to the Company such
information regarding

                                       11
<PAGE>

such Holder or Founder and the distribution proposed by such Holder or Founder
as the Company may reasonably request in writing and as shall be reasonably
required in connection with any registration, qualification, or compliance
referred to in this Section 1.

     1.10  Limitations on Subsequent Registration Rights.  From and after the
date of this Agreement, the Company shall not, without the prior written consent
of the holders of at least two-thirds of the Registrable Securities, voting as
one class, enter into any agreement with any holder or prospective holder of any
securities of the Company giving such holder or prospective holder any
registration rights the terms of which are superior to or on a parity with the
registration rights granted to the Holders hereunder; provided, however, the
Company may grant registration rights, on a parity with the registration rights
granted to the Holders hereunder, to Alexandria Real Estate Equities, Inc. or an
affiliate thereof ("Alexandria") relating to certain stock purchase warrants to
be issued to Alexandria by the Company in connection with a real estate
financing transaction between the Company and Alexandria.

     1.11  Rule 144 Reporting.  With a view to making available the benefits of
certain rules and regulations of the Commission that may permit the sale of the
Registrable Securities and Founders' Shares to the public without registration,
the Company agrees to use its best efforts to:

          (a) make and keep public information regarding the Company available
as those terms are understood and defined in Rule 144 under the Securities Act,
at all times from and after 90 days following the effective date of the first
registration under the Securities Act filed by the Company for an offering of
its securities to the general public;

          (b) file with the Commission in a timely manner all reports and other
documents required of the Company under the Securities Act and the Exchange Act
at any time after it has become subject to such reporting requirements; and

          (c) so long as a Holder owns any Registrable Securities, furnish to
the Holder forthwith upon written request as to the Company's compliance with
the reporting requirements of Rule 144 (at any time from and after 90 days
following the effective date of the first registration statement filed by the
Company for an offering of its securities to the general public), and of the
Securities Act and the Exchange Act (at any time after it has become subject to
such reporting requirements), a copy of the most recent annual or quarterly
report of the Company.

     1.12  Transfer or Assignment of Registration Rights.  The rights to cause
the Company to register securities granted to a Holder or a Founder by the
Company under this Section 1 may be transferred or assigned by a Holder or a
Founder only to (a) in the case of a Holder, to an affiliate of such Holder or
to such Holder's partners or retired partners in accordance with their rights in
the partnership or (b) a transferee or assignee of not less than 20% of such
Holder's Registrable Securities or such Founder's Shares (as determined on the
date of this Agreement and subject to subsequent adjustments for stock splits,
stock dividends, reverse stock splits, and the like), provided that, in either
case (i) the Company is given written notice at the time of or within 30 days
after transfer or assignment, stating the name and address of the transferee or
assignee and identifying the securities with respect to which such registration
rights are being transferred or assigned, (ii) the transferee or assignee of
such rights assumes in writing the obligations of such Holder or Founder under
this Section 1 and (ii)

                                       12
<PAGE>

in the reasonable opinion of the Company, the transferee is neither a competitor
to the Company nor a party who is or could likely become demonstrably hostile to
the Company.

     1.13  "Market Stand-Off" Agreement.  If requested by the Company and an
underwriter of Common Stock (or other securities) of the Company, neither an
Investor nor a Founder shall sell or otherwise transfer or dispose of any Common
Stock (or other securities) of the Company held by such Investor or Founder
(other than those included in the registration) during a period not to exceed
180 days following the effective date of a registration statement of the Company
filed under the Securities Act, provided that all officers and directors of the
Company and holders of at least five percent of the Company's voting securities
are bound by and have entered into similar agreements.

     The obligations described in this Section 1.13 shall not apply to a
registration relating solely to employee benefit plans on Form S-1, Form S-3 or
Form S-8 or similar forms that may be promulgated in the future, or a
registration relating solely to a Commission Rule 145 transaction on Form S-4 or
similar forms that may be promulgated in the future.  The Company may impose
stop-transfer instructions with respect to the shares of Common Stock (or other
securities) subject to the foregoing restriction until the end of such 180 day
period.

     1.14  Allocation of Registration Opportunities.  In any circumstance in
which all of the Registrable Securities and other shares of Common Stock of the
Company (including shares of Common Stock issued or issuable upon conversion of
shares of any currently unissued series of Preferred Stock of the Company) with
registration rights (the "Other Shares") requested to be included in a
registration on behalf of the Holders or other selling stockholders cannot be so
included as a result of limitations of the aggregate number of shares of
Registrable Securities and Other Shares that may be so included, the number of
shares of Registrable Securities and Other Shares that may be so included shall
be allocated first to the Holders, second to the Founders and then among the
other selling stockholders requesting inclusion of shares, in each case pro rata
on the basis of the number of shares of Registrable Securities and Other Shares
that would be held by such Holders, Founders, and other selling stockholders,
assuming conversion; provided, however, that such allocation shall not operate
to reduce the aggregate number of Registrable Securities and Other Shares to be
included in such registration, if any Holder or other selling stockholder does
not request inclusion of the maximum number of shares of Registrable Securities
and Other Shares allocated to him pursuant to the above-described procedure, and
the remaining portion of his allocation shall be reallocated among those
requesting Holders and other selling stockholders whose allocations did not
satisfy their requests pro rata on the basis of the number of shares of
Registrable Securities and Other Shares which would be held by such Holders and
other selling stockholders, assuming conversion, and this procedure shall be
repeated until all of the shares of Registrable Securities and Other Shares
which may be included in the registration on behalf of the Holders and other
selling stockholders have been so allocated.  The Company shall not limit the
number of Registrable Securities to be included in a registration pursuant to
this Agreement in order to include shares held by stockholders with no
registration rights or to include Founders' Shares or any other shares of stock
issued to employees, officers, directors, or consultants pursuant to a Company
Stock Option Plan, or with respect to registrations under Sections 1.3 or 1.5
hereof, in order to include in such registration securities registered for the
Company's own account.

                                       13
<PAGE>

     1.15  Delay of Registration.  No Holder or Founder shall have any right to
take any action to restrain, enjoin, or otherwise delay any registration as the
result of any controversy that might arise with respect to the interpretation or
implementation of this Section 1.

     1.16  Suspension.  The Holders and Founders agree that, upon receipt of any
notice from the Company of the existence of any state of facts or the occurrence
of any event (including without limitation pending negotiations relating to, or
the consummation of, a transaction, or the occurrence of any event which in the
reasonable opinion of the Company might require additional disclosure of
material, non-public information by the Company in any registration statement
provided for in this Agreement as to which the Company believes in good faith
that it has a bona fide business purpose for preserving confidentiality or which
renders the Company unable to comply with the published rules and regulations of
the Commission promulgated under the Securities Act or the Exchange Act, as in
effect at any relevant time) which might reasonably result in (A) such
registration statement, any amendment or post-effective amendment thereof, or
any document incorporated therein by reference containing an untrue statement of
a material act or omitting to state a material fact required to be stated
therein or necessary to make the statements therein not misleading, or (B) the
prospectus issued under such registration statement, any prospectus supplement,
or any document incorporated therein by reference including an untrue statement
of material fact or omitting to state a material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were
made, not misleading, the Holders and Founders will forthwith discontinue
disposition of the Registrable Securities or Founders' Shares pursuant to such
registration statement for a period which is the shorter of (a) 30 calendar days
from the Company's notice to such Holders or (b) until the Holders and Founders
receive copies of prospectus supplements or amendments prepared by or on behalf
of the Company.  If so directed by the Company, the Holders and Founders will
deliver to the Company all copies in their possession of the prospectus covering
such Registrable Securities or Founders' Shares current at the time of receipt
of such notice.  The Company shall not be permitted to require the suspension of
the disposition of Registrable Securities or Founders' Shares for a period in
excess of 90 calendar days or in excess of two times in each case per rolling 12
month period.

     1.17  Termination of Registration Rights.  The rights to request
registration of any Company securities pursuant to Sections 1.3, 1.4 and 1.5
shall terminate as to any Holder who holds Registrable Securities or any Founder
upon the earlier of: (a) when a Holder holds one percent or less of the
Company's Common Stock on an as-converted basis; (b) when all of a Holder's
Registrable Securities may be sold during a single three month period under Rule
144; (c) when a Holder's Registrable Securities may be transferred under Rule
144(k) unless such Holder later becomes an affiliate of the Company (as defined
in Rule 144) in which case such Holder's rights to request registration shall be
revived until such Holder's rights otherwise terminate under this Section 1.17;
and (d) three years after the closing of a firm commitment underwritten public
offering pursuant to an effective registration statement under the Securities
Act covering the offer and sale of the Company's Common Stock at a price per
share of not less than $10.00 (as adjusted for stock splits, dividends,
combinations and the like) and an aggregate offering price to the public of not
less than $20,000,000.  Such three-year period shall not include any period of
time during which adequate current public information, as defined in Rule 144(c)
promulgated under the Securities Act, is not available with respect to the
Company.

                                       14
<PAGE>

SECTION 2.  MISCELLANEOUS.

     2.1  Governing Law.  This Agreement shall be governed in all respects by
the laws of the State of North Carolina.

     2.2  Successors and Assigns.  Except as otherwise expressly provided
herein, the provisions hereof shall inure to the benefit of, and be binding
upon, the successors, assigns, heirs, executors and administrators of the
parties hereto.

     2.3  Entire Agreement; Amendment; Waiver.  This Agreement (including the
Exhibits hereto) constitutes the full and entire understanding and agreement
between the parties with regard to the subject matter hereof and thereof.
Neither this Agreement nor any term hereof may be amended, waived, discharged or
terminated, except by a written instrument signed by the Company and the holders
of at least two-thirds of the Registrable Securities, voting as one class, and
any such amendment, waiver, discharge or termination shall be binding on all
holders, but in no event shall the obligation of any Holder hereunder be
materially increased, except upon the written consent of such Holder. This
Agreement supercedes the Original Registration Rights Agreement and the Restated
Registration Rights Agreement.

     2.4  Notices.  All notices and other communications required or permitted
hereunder shall be in writing and shall be mailed by United States first-class
mail, postage prepaid, sent by facsimile or delivered personally by hand or
nationally recognized courier addressed (a) if to a Holder or Founder, as
indicated on the signature page, or at such other address as such holder or
permitted assignee shall have furnished to the Company in writing, or (b) if to
the Company, at such address or facsimile number as the Company shall have
furnished to each Holder in writing.  All such notices and other written
communications shall be effective on the date of mailing, facsimile transfer or
delivery.

     2.5  Delays or Omissions.  No delay or omission to exercise any right,
power or remedy accruing to any Holder or Founder, upon any breach or default of
the Company under this Agreement shall impair any such right, power or remedy of
such Holder or Founder nor shall it be construed to be a waiver of any such
breach or default, or an acquiescence therein, or of or in any similar breach or
default thereafter occurring; nor shall any waiver of any single breach or
default be deemed a waiver of any other breach or default therefore or
thereafter occurring.  Any waiver, permit, consent or approval of any kind or
character on the part of any Holder or Founder of any breach or default under
this Agreement or any waiver on the part of any Holder or Founder of any
provisions or conditions of this Agreement must be made in writing and shall be
effective only to the extent specifically set forth in such writing.  All
remedies, either under this Agreement or by law or otherwise afforded to any
Holder or Founder, shall be cumulative and not alternative.

     2.6  Rights; Severability.  Unless otherwise expressly provided herein, a
Holder's or Founder's rights hereunder are several rights, not rights jointly
held with any of the other Holders or Founders.  In case any provision of the
Agreement shall be invalid, illegal or unenforceable, the validity, legality and
enforceability of the remaining provisions shall not in any way be affected or
impaired thereby.  Furthermore, upon request of any party hereto, the parties to
this Agreement shall add, in lieu of such invalid or unenforceable provisions,
provisions as similar in terms to such invalid or unenforceable provisions as
may be possible and legal, valid and enforceable.

                                       15
<PAGE>

     2.7  Information Confidential.  Each party acknowledges that the
information received by them pursuant hereto may be confidential and for its use
only, and it will not use such confidential information in violation of the
Securities Act or Exchange Act or reproduce, disclose or disseminate such
information to any other person (other than its employees or agents having a
need to know the contents of such information, and its attorneys), except in
connection with the exercise of rights under this Agreement, unless the Company
has made such information available to the public generally or such party is
required to disclose such information by a governmental body.

     2.8   Titles and Subtitles. The titles of the paragraphs and subparagraphs
of this Agreement are for convenience of reference only and are not to be
considered in construing or interpreting this Agreement.

     2.9   Execution; Counterparts. This Agreement may be executed in any number
of counterparts, each of which shall be an original, but all of which together
shall constitute one instrument. This Agreement may be executed and delivered by
telecopy or facsimile and any execution in such manner shall be deemed an
original.

     2.10  Further Assurances.  The parties agree, from time to time and without
further consideration, to execute and deliver such further documents and take
such further actions as reasonably may be required to implement and effectuate
the transactions contemplated in this Agreement.

     2.11  No Third-Party Beneficiaries.  This Agreement is intended to inure to
the benefit of the parties hereto only, and no other person shall have any
rights, express or implied, by reason of this Agreement.

     2.12  Listing of Shares.  The Company shall use its best efforts to cause
all Common Stock held by the Investors to be listed on each securities exchange
or market on which similar securities issued by the Company are then listed.

                     [signature pages appear on next page]

                                       16
<PAGE>

     IN WITNESS WHEREOF, the parties hereto have executed this Amended and
Restated Registration Rights Agreement effective as of the day and year first
above written.

                         PARADIGM GENETICS INC.

                         By:  ________________________________________
                         Name:
                         Title:
                         Address:  104 Alexander Drive
                                   Building 2
                                   Research Triangle Park, NC
                                   27709-4528

                         INVESTORS:

                         THE BURRILL AGBIO CAPITAL FUND, L.P.

                         By:  Burrill & Company LLC,
                              its General Partner

                         By:  ________________________________________
                         Name:
                         Title:
                         Address:  120 Montgomery Street
                                   Suite 1370
                                   San Francisco, CA 94104

                         INNOTECH INVESTMENTS LIMITED

                         By:  ________________________________________
                         Name:
                         Title:
                         Address:  3 Charterhouse Mews
                                   Charterhouse Square
                                   London EC1M 6BB
                                   England

<PAGE>

         [signature page to Paradigm Genetics Inc. Amended and Restated
                         Registration Rights Agreement]

                         Intersouth Partners Iv, L.P.

                         By:  Intersouth Associates IV, L.L.C.,
                              its General Partner

                         By:  ________________________________________
                         Name:
                         Title:    Member Manager
                         Address:  One Copley Parkway
                                   Suite 102
                                   Morrisville, North Carolina  27560

                         Intersouth Partners III, L.P.

                         By:  Intersouth Associates III, L.P.,
                              its General Partner

                         By:  ________________________________________
                         Name:
                         Title:    General Partner
                         Address:  One Copley Parkway
                                   Suite 102
                                   Morrisville, North Carolina  27560

                         LION BIOSCIENCE AG

                         By:  ________________________________________
                         Name:
                         Title:
                         Address:  Waldhofer Str. 98
                                   69123 Heidelberg
                                   Germany

<PAGE>

         [signature page to Paradigm Genetics Inc. Amended and Restated
                         Registration Rights Agreement]

                         POLARIS VENTURE PARTNERS III, L.P.

                         By:  Polaris Venture Management Co. III, LLC
                              its General Partner

                         By:  ________________________________________
                         Name:
                         Title:    Member
                         Address:  1000 Winter Street
                                   Suite 3350
                                   Waltham, Massachusetts 02154

                         POLARIS VENTURE PARTNERS, L.P.

                         By:  Polaris Venture Management Co., LLC
                              its General Partner

                         By:  ________________________________________
                         Name:
                         Title:    Member
                         Address:  1000 Winter Street
                                   Suite 3350
                                   Waltham, Massachusetts 02154

                         POLARIS VENTURE PARTNERS FOUNDERS'
                         FUND, L.P.

                         By:  Polaris Venture Management Co., LLC
                              its General Partner

                         By  ________________________________________
                         Name:
                         Title:    Member
                         Address:  1000 Winter Street
                                   Suite 3350
                                   Waltham, Massachusetts 02154

<PAGE>

         [signature page to Paradigm Genetics Inc. Amended and Restated
                         Registration Rights Agreement]

                         THE BAY CITY CAPITAL FUND I, L.P.

                         By  ________________________________________
                         Name:
                         Title:
                         Address:  750 Battery Street
                                   Suite 600
                                   San Francisco, California 94111

                         FOUNDERS:

                         ______________________________________________
                         JOHN A.  RYALS
                         104 Alexander Drive
                         Building 2
                         Research Triangle Park, NC  27709-4528

                         ______________________________________________
                         JORN GORLACH
                         104 Alexander Drive
                         Building 2
                         Research Triangle Park, NC  27709-4528

                         ______________________________________________
                         SANDY J. STEWART
                         104 Alexander Drive
                         Building 2
                         Research Triangle Park, NC  27709-4528

                         ______________________________________________
                         SCOTT J. UKNES
                         104 Alexander Drive
                         Building 2
                         Research Triangle Park, NC  27709-4528

<PAGE>

                                   EXHIBIT A
                                 STOCKHOLDERS:

                                   INVESTORS:
                      The Burrill Agbio Capital Fund, L.P.
                          Innotech Investments Limited
                         Intersouth Partners III, L.P.
                          Intersouth Partners IV, L.P.
                               Lion Bioscience AG
                       Polaris Venture Partners III, L.P.
                         Polaris Venture Partners, L.P.
                 Polaris Venture Partners Founders' Fund, L.P.
                       The Bay City Capital Fund I, L.P.

                                   FOUNDERS:
                                 John A. Ryals
                                  Jorn Gorlach
                                Sandy J. Stewart
                                 Scott J. Uknes

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00002-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00002-of-00352.parquet"}]]